Journal of Life Science (생명과학회지)

Korean Society of Life Science (한국생명과학회)
권호 표지
DOI QR코드

DOI QR Code

Identification of Novel Mutations In Adenosine Deaminase Gene In Korean Leukemia Patients

한국인 백혈병 환자에서 아데노신 디아미나제 유전자의 새로운 변이의 확인

  • Park, Ki-Ho (Department of Pediatrics, Wallace Memorial Baptist Hospital)
  • Received : 2009.10.13
  • Accepted : 2009.10.30
  • Published : 2010.03.30
Download PDF
⟨ Previous Next ⟩

Abstract

Leukemia is the abnormal increase of hematopoietic progenitor cells in tissues, resulting in anemia, increased susceptibility to infection and impaired blood clotting. The adenosine deaminase (ADA) gene is an important druggable target for the treatment of leukemia patients. Genetic and molecular analyses were performed to determine the effects of ADA gene mutations in 20 leukemia patients in the Korean population. To analyze the relationship between genotype and phenotype, the ADA genomic DNAs - including 1,092 bp of 12 exons and partial intron sequences flanking each exon - were sequenced and compared. In this study, the known mutations in other diseases, more than 50 mutations already reported in patients with severe combined immunodeficiency disease (SCID) and autism, were not found, but two novel mutations in leukemia patients were discovered. They include one nonsense mutation (A>C at nt position 478, F101F) and one missense mutation (G>A at nt position 778, E260K). One missense mutation (G>A at nt position 22, D8Y) was also detected in 20 normal control patients (allelic frequency of 7.5%). Interestingly, subjects in the Korean population retained 2 bp insertion at the intron 6 (IVS6-52insGC), something that has never been shown in other populations. The genetic study to find out the correlation between the mutant alleles and leukemia patients revealed no association statistically (p>0.05). The mutation found in leukemia needs further study to determine its possibility as a molecular marker for the diagnosis of leukemia.

백혈병은 조혈모세포의 비정상적인 증식에 의해 일어나서 질환이고, adenosine deaminase (ADA) 유전자는 백혈병의 약물 작용점으로 중요하다. 이러한 연구의 일환으로 한국인 백혈병 환자 20명의 ADA 유전자의 변이를 조사하기 위해 혈액 genomice DNA를 추출하여 염기서열을 결정하였다. 그 결과 nonsense 변이인 F101F 하나, missense 변이 E260K, D8Y 각각 하나, 그리고 외국에서는 보고되지 않은 것으로 정상인에서 IVS6-52 에 GC가 도입된 것을 확인하였다. 백혈병 환자와 유전자 변이간에 통계학적인 차이점은 없지만 이러한 연구는 앞으로 백혈병의 진단 마크 개발에 도움이 될 것으로 사료된다.

Keywords

References

  1. Arredondo-Vega, F. X., I. Santisteban, S. Daniels, S. Toutain, and M. S. Hershfield. 1998. Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles. Am. J. Hum. Genet. 63, 1049-1059. https://doi.org/10.1086/302054
  2. Bottini, N., D. De Luca, P. Saccucci, A. Fiumara, M. Elia, M. C. Porfirio, P. Lucarelli, and P. Curatolo. 2001. Autism: evidence of association with adenosine deaminase genetic polymorphism. Neurogenetics 3, 111-113. https://doi.org/10.1007/s100480000104
  3. Bottini, N., F. Gloria-Bottini, P. Borgiani, E. Antonacci, P. Lucarelli, and E. Bottini. 2004. Type 2 diabetes and the genetics of signal transduction: a study of interaction between adenosine deaminase and acid phosphatase locus 1 polymorphisms. Metabolism 53, 995-1001. https://doi.org/10.1016/j.metabol.2004.03.006
  4. Cassani, B., M. Mirolo, F. Cattaneo, U. Benninghoff, M. Hershfield, F. Carlucci, A. Tabucchi, C. Bordignon, M. G. Roncarolo, and A. Aiuti. 2008. Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients. Blood 111, 4209-4219. https://doi.org/10.1182/blood-2007-05-092429
  5. Cristalli, G., S. Costanzi, C. Lambertucci, G. Lupidi, S. Vittori, R. Volpini, and E. Camaioni. 2001. Adenosine deaminase: functional implications and different classes of inhibitors. Med. Res. Rev. 21, 105-128. https://doi.org/10.1002/1098-1128(200103)21:2<105::AID-MED1002>3.0.CO;2-U
  6. Cruciani, F., L. Bernardini, P. Santolamazza, D. Modiano, A. Torroni, and R. Scozzari. 2003. Linkage disequilibrium analysis of the human adenosine deaminase (ada) gene provides evidence for a lack of correlation between hot spots of equal and unequal homologous recombination. Genomics 82, 20-33. https://doi.org/10.1016/S0888-7543(03)00096-X
  7. Hirschhorn, R., S. Tzall, and A. Ellenbogen. 1990. Hot spot mutations in adenosine deaminase deficiency. Proc. Natl. Acad. Sci. USA 87, 6171-6175. https://doi.org/10.1073/pnas.87.16.6171
  8. Jhanwar, S. C., T. M. Berkvens, C. Breukel, H. van Ormondt, A. J. van der Eb, A. J. Meera, and P. Khan. 1989. Localization of human adenosine deaminase (ADA) gene sequences to the q12----q13.11 region of chromosome 20 by in situ hybridization. Cytogenet. Cell Genet. 50, 168-171. https://doi.org/10.1159/000132752
  9. Jiang, C., R. Hong, S. D. Horowitz, X. Kong, and R. Hirschhorn. 1997. An adenosine deaminase (ADA) allele contains two newly identified deleterious mutations (Y97C and L106V) that interact to abolish enzyme activity. Hum. Mol. Genet. 6, 2271-2278. https://doi.org/10.1093/hmg/6.13.2271
  10. Lucarelli, P., P. Saccucci, N. Bottini, D. De Luca, A. Fiumara, M. Elia, M. C. Porfirio, and P. Curatolo. 2002. Two-loci ADA haplotypes in autistic disorder. Am. J. Med. Genet. 108, 339-340. https://doi.org/10.1002/ajmg.10272
  11. Ozsahin, H., F. X. Arredondo-Vega, I. Santisteban, H. Fuhrer, P. Tuchschmid, W. Jochum, A. Aguzzi, H. M. Lederman, A. Fleischman, J. A. Winkelstein, R. A. Seger, and M. S. Hershfield. 1997. Adenosine deaminase deficiency in adults. Blood 89, 2849-2855.
  12. Santisteban, I., F. X. Arredondo-Vega, S. Kelly, A. Mary, A. Fischer, D. S. Hummell, A. Lawton, R. U. Sorensen, E. R. Stiehm, and L. Uribe L. 1993. Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype. J. Clin. Invest. 92, 2291-2302. https://doi.org/10.1172/JCI116833
  13. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25, 4876-4882. https://doi.org/10.1093/nar/25.24.4876
  14. Valerio, D., M. G. Duyvesteyn, B. M. Dekker, G. Weeda, T. M. Berkvens, L. van der Voorn, H. van Ormondt, and A. J. van der Eb. 1985. Adenosine deaminase: characterization and expression of a gene with a remarkable promoter. EMBO J. 4, 437-443.
  15. Valerio, D., M. G. Duyvesteyn, H. van Ormondt, P. Meera Khan, and A. J. van der Eb. 1984. Adenosine deaminase (ADA) deficiency in cells derived from humans with severe combined immunodeficiency is due to an aberration of the ADA protein. Nucleic Acids Res. 12, 1015-1024. https://doi.org/10.1093/nar/12.2.1015
  16. Wiginton, D. A., G. S. Adrian, R. L. Friedman, D. P. Suttle, and J. J. Hutton. 1983. Cloning of cDNA sequences of human adenosine deaminase. Proc. Natl. Acad. Sci. USA 80, 7481-7485. https://doi.org/10.1073/pnas.80.24.7481